Alkermes plc is a pharmaceutical manufacturing and biopharmaceutical company developing innovative medicines to help patients with serious chronic conditions.
View all
Abcam
Post IPO Equity
Alexion Pharmaceuticals
New Haven, United States · Post IPO Equity
BioNTech
Berlin, Germany · Post IPO Equity
Genmab
Copenhagen, Denmark · Post IPO Equity
Vertex Pharmaceuticals
Boston, United States · Post IPO Equity
Repligen
Waltham, United States · Post IPO Equity
Seattle Genetics
Bothell, United States · Post IPO Equity
bluebird bio
Cambridge, United States · Post IPO Equity
Natera
Austin, United States · Post IPO Equity
Galapagos
Mechelen, Belgium · Post IPO Equity
Amneal Pharmaceuticals
Bridgewater, United States · Post IPO Equity
PTC Therapeutics
South Plainfield, United States · Post IPO Equity